$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of Spasentan (Sparsentan) imported drug price and purchasing reference information
2026-02-01 22:25:32
Check Details
Can ixazomib (Enleri) be used in combination with dexamethasone and precautions
2026-02-01 22:25:32
Check Details
Detailed explanation of the contents and medication guide of Rubitidine/Rubicatin (Zanbiga)
2026-02-01 22:25:32
Check Details
The efficacy of everolimus (Afinitor) on tumor shrinkage and patient feedback evaluation
2026-02-01 22:25:32
Check Details
What kind of drugs does estramustine (Adelox) belong to and its mechanism of action?
2026-02-01 22:25:32
Check Details
Clinical efficacy evaluation of seripalase (BRINEURA) and analysis of patient effects after use
2026-02-01 22:25:32
Check Details
The real answer to whether Eslicarbazepine must be used for life after taking it
2026-02-01 22:25:32
Check Details
Detailed explanation of which effect is more superior between Anagrelide and interferon treatment
2026-02-01 22:25:32
Check Details
Will there be drug resistance after taking apalutamide (Ansenko) and its treatment plan?
2026-02-01 22:25:32
Check Details
What are the common side effects of Elacetrant? What should patients pay attention to when taking it?
2026-02-01 22:25:32
Check Details
Details of the official instructions for F/TAF and information that patients must understand before taking it
2026-02-01 22:25:32
Check Details
Analysis of the comparative efficacy and applicable patient groups of febuxostat (fibrebide) and colchicine
2026-02-01 22:25:32
Check Details
1
2
...
2166
2167
2168
2169
2170
2171
2172
...
10240
10241
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
2
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
3
Weight Gain and Edema Management, Monitoring of Repotrectinib (Augtyro) During Treatment
4
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
5
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
6
Selumetinib for NF1-Related Plexiform Neurofibromas: Time to Response and Response Assessment
7
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
8
Ganaxolone Common Side Effects: Somnolence, Sedation and Safety Notes
9
Baxdrostat: Efficacy and Safety of a Novel Aldosterone Synthase Inhibitor
10
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
11
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
12
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks